ARCHIVES

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 03 | January 17, 2003

Download PDF Visit The Full Archive

Related Articles

New Version Of NCI Proposed IP Agreement Quiets Some Unease At Cooperative Groups; Advisors Urge “No Paralysis” While Awaiting New Language

November 13, 2009

Seer Gets Extra $5000,000 to Permit Addition Of One Registry To Braden Coverage Of Blacks, Hispanics

October 22, 1982

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012

The Walgreens Connection: ACS Calls On Drug Stores To Stop Tobacco Sales

April 18, 2014